FDA approves Dupixent for chronic obstructive pulmonary disease
WEB2 days ago · The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary...
COPD News - ScienceDaily
WEB5 days ago · Latest research news on COPD, including chronic bronchitis, chronic obstructive airway disease, chronic obstructive lung disease and emphysema.
Smoking is the leading cause of chronic obstructive pulmonary disease
WEBNov 15, 2023 · A new brief reveals that smoking remains one of the leading causes of chronic obstructive pulmonary disease (COPD), a common lung disease that causes breathing problem and claiming the lives of over 3 million people every year.
2024 GOLD Report Reflects New Research on COPD Management
WEBDec 8, 2023 · The 2024 GOLD Report, “Global Strategy for Prevention Diagnosis and Management of COPD,” not only includes guideline updates that reflect the latest research on chronic obstructive pulmonary disease (COPD); it also reflects some shifts in thinking about what’s important in COPD treatment, according to Claus Vogelmeier, MD, a …
Chronic obstructive pulmonary disease (COPD)
WEBMar 16, 2023 · WHO fact sheet on chronic obstructive pulmonary disease (COPD) provides key facts and information on symptoms, diagnosis and treatment, risk factors and WHO response.
Dupilumab for COPD with Type 2 Inflammation Indicated by …
WEBMay 21, 2023 · Chronic obstructive pulmonary disease (COPD) is often associated with markedly reduced lung function and an increased risk of exacerbations, 1-3 which are characterized by a worsening of...
Immune treatment tackles chronic obstructive pulmonary disease …
WEBAug 16, 2023 · Chronic obstructive pulmonary disease (COPD) is a common lung disease caused by tobacco smoke and other airborne pollutants, and it can be fatal. COPD exacerbations — defined as acute...
Updated 2023 GOLD Report Revises COPD Definitions and …
WEBJan 20, 2023 · The 2023 report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) — “Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease” (COPD) 1 — details “an expanded range of therapies for COPD that now can be considered to improve mortality,” according to Gerard J. Criner, MD, FACP, FA...
GOLD COPD report: 2023 update - The Lancet Respiratory Medicine
WEBOn Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published their 2023 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).
Eliminating tobacco smoking could help increase life expectancy …
WEB2 days ago · Cancers, ischemic heart disease, and chronic obstructive pulmonary disease (COPD) are—and will continue to be—the leading causes of premature deaths from smoking. Together, these...